Sector: Technology | Industry: Software |
Company Contact | |
Address: | 16 Natan Alterman St GAN YAVNE TX 7085118 |
Tel: | N/A |
Website: | N/A |
IR: | N/A |
Key People | ||
Boris Molchadsky Chairman of the Board | Adi Shemer Chief Executive Officer | Asaf Porat Chief Financial Officer, Director |
Business Overview |
AppYea, Inc. is a digital health company, which is focused on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring and fundamentally improve quality of life. The Company's business plan focuses on two principal devices and an App in development: DreamIT and DreamIT PRO, and SleepX PRO. DreamIT is a biofeedback snoring treatment wristband, combined with the SleepX App and this wristband uses algorithms designed by SleepX combined with sensors to monitor physiological parameters during sleep. DreamIT PRO is a wristband for the treatment of sleep apnea using biofeedback in combination with the SleepX PRO app. The algorithms of SleepX PRO, combined with the wristband sensors, monitor sleep apnea events and additional physiological parameters during sleep, and when necessary. SleepX PRO is a medical application that is used to monitor breathing patterns in sleep and identify sleep apnea episodes without direct contact with the user. |
Financial Overview |
For the fiscal year ended 31 December 2023, AppYea Inc revenues was not reported. Net loss increased 39% to $1.8M. Higher net loss reflects Fair Value Adjustments on Other Assets decrease of 71% to $262K (income), Financial income (expenses), net increase from $52K to $441K (expense), General and administrative expenses - Ba increase from $45K to $194K (expense). |
Employees: | 9 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $10.52M as of Dec 31, 2023 |
Annual revenue (TTM): | $0.00M as of Dec 31, 2023 |
EBITDA (TTM): | -$1.61M as of Dec 31, 2023 |
Net annual income (TTM): | -$1.82M as of Dec 31, 2023 |
Free cash flow (TTM): | -$0.60M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1.86M as of Dec 31, 2023 |
Shares outstanding: | 416,697,257 as of Mar 31, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |